UCL SLMS is a part of London’s research powerhouse, with a commitment to research that addresses some of the world’s most pressing problems.
Our work covers the full range of enquiry in biomedical, life and population health sciences.
- In the Research Excellence Framework 2014, an average of 78% of our research was graded as internationally excellent or world-leading and we were identified as the UK’s strongest medical research grouping.
- UCL has made cross-disciplinary research a priority and the UCL Research Domains provide strategic coordination across the university and a platform for research communities to engage with partner organisations.
The UCL Research Domains are
large, cross-disciplinary research communities that span UCL and our partner
organisations, fostering interaction and collaboration.
We believe that by bringing together a critical mass of expertise we can undertake internationally leading research in our key areas of strength.
Find out more by visiting the domain pages
The Research Excellence Framework is the system for assessing the quality of research in UK higher education institutions.
UCL and REF2014
SLMS and REF2014
Panel A power rankings
We achieved the greatest amount of 4* (world leading) research in Panel A, covering medicine and biological sciences, much of which is conducted in collaboration with our partner hospitals.
UCL SLMS Quality Profile REF2014
78% of our research was graded as internationally excellent or world leading:
UCL SLMS Power Rankings REF2014
Our institutional submission rate is amongst the highest in the sector reflecting our role as a truly research-intensive university, where a supportive environment empowers members of our research community to achieve their potential as world-leading researchers.
The REF2014 power rankings identified us as the UK’s strongest medical research grouping.
How it works
The assessment criteria
The overall quality profile is comprised of the aggregate of the weighted sub-profiles produced for outputs (65%), impact (20%) and environment
(15%). Institutions can be ranked on a grade-point average and in terms
of research power (a mixture of excellence and volume).
Overall quality profile: Definitions of starred levels
|Four star||Quality that is world-leading in terms of originality, significance and rigour.|
|Three star||Quality that is internationally excellent in terms of originality, significance and rigour but which falls short of the highest standards of excellence.|
|Two star||Quality that is recognised internationally in terms of originality, significance and rigour.|
|One star||Quality that is recognised nationally in terms of originality, significance and rigour.|
|Unclassified||Quality that falls below the standard of nationally recognised work. Or work which does not meet the published definition of research for the purposes of this assessment.|
- Visit the REF2014 webpages for more detail on the assessment criteria
Individually and in collaboration, UCL experts develop insights relevant
to the great challenges facing the world. Society reaps many benefits
from their excellent research, some of which occur immediately, while
others develop over years or generations.
We encourage our researchers to think creatively about how their work intersects with the world outside academia, and provide mechanisms to bring their wealth of knowledge, creativity and insight to the people and organisations who need it most.
SLMS Impact Case Studies
The Code of Conduct for Research states that UCL is committed to maintaining the integrity and probity of academic research. UCL regards it as fundamental that research should be conducted, and the results of research disseminated, honestly, accurately and in accordance with professional standards.
Our dedicated animal research information website explains how UCL conducts animal research.
It includes descriptions of the processes governing research and the ‘3Rs’: replacing animal research with alternatives, reducing the number of animals used and refining experiments to minimise harm and discomfort to the animals. The site also lists up-to-date figures of how many animals of each species were used in UCL research last year.
The Institutional Research Information System (IRIS) is the UCL research portal.
You can user it to identify the research activities of researchers,
research groups, research centres and interdisciplinary networks across
the whole of UCL. In addition you can search UCL's world class publications.
SLMS is committed to supporting staff development, succession planning and empowering staff to share in leadership.
Alongside key initiatives - such as the Future Leaders Programme – a key element of this process is standardising leadership responsibilities. The Duties and Responsibilities of Heads of Research Departments in SLMS were confirmed wef 1/10/14 (these can be found at http://www.ucl.ac.uk/slms/slms-intranet/human-resources).
It has been agreed that SLMS Faculties will work with Institutes to agree proposals for succession planning in the academic year 2014-15, with change being implemented as appropriate and agreed, but with the expectation that this will normally be achieved within the following two academic years, so by 30/9/17.
Faculty of Brain Sciences
Division of Psychology and Language Sciences
|Prof Peter Fonagy||Clinical, Educational, and Health Psychology||TBC|
|Dr Joseph Devlin||Experimental Psychology||30/09/2018|
|Prof Neil Burgess||Institute of Cognitive Neuroscience||30/09/2019|
|Prof Rosemary Varley||Language & Communication||30/09/2018|
|Prof Ad Neeleman||Linguistics||30/06/2017|
|Prof Valerie Hassan||Speech, Hearing and Phonetic Sciences||31/08/2019|
|Prof Yvonne Rogers||UCL Interaction Centre||30/09/2016|
Institute of Neurology
|Prof Xavier Golay||Brain Repair & Rehabilitation||TBC|
|Prof Matthew Walker||Clinical and Experimental Epilepsy||TBC|
|Prof Anthony Schapira||Clinical Neuroscience (Hampstead Campus)||TBC|
|Prof John Hardy||Molecular Neuroscience||TBC|
|Prof John Collinge||Neurodegenerative Disease||TBC|
|Prof Kenneth J Smith||Neuroinflammation||TBC|
|Prof Linda Greensmith||Sobell Dept of Motor Neuroscience and Movement Disorders||TBC|
|Prof Ray Dolan||Wellcome Trust Centre for Neuroimaging||TBC|
|Prof Tom Warner||Reta Lila Weston Institute||TBC|
Institute of Ophthalmology
|Prof John Greenwood||Cell Biology||TBC|
|Prof Robin Ali||Genetics||TBC|
|Prof Pete Coffey||Ocular Biology & Theraputics (ORBIT)||TBC|
|Prof Gary Rubin||Visual Neuroscience||TBC|
Faculty of Life Sciences
Division of Biosciences
|Prof Stephen Hunt||Cell & Developmental Biology||29/02/2016|
|Prof Andrew Pomiankowski||Genetics, Evolution & Environment||31/07/2019|
|Prof Trevor Smart||Neuroscience, Physiology & Pharmacology||31/07/2016|
|Prof Gabriel Waksman||Structural & Molecular Biology||31/12/2019|
School of Pharmacy
|Prof Frank Kozielski||Pharmaceutical & Biological Chemistry||31/12/2018|
|Dr Simon Gaisford||Pharmaceutics||28/10/2016|
|Dr Brian Pearce||Pharmacology||31/12/2018|
|Prof Ian Wong||Practice & Policy||
Faculty of Medical Sciences
Division of Medicine
|Prof William Richardson||Wolfson Institute for Biomedical Research||19/04/2016|
|Prof Mervyn Singer||Clinical Physiology||31/12/2015|
|Prof Ian Zachary||Metabolism and Experimental Therapeutics||31/12/2015|
|Prof David Abraham||Inflammation||31/12/2015|
|Prof Robert Unwin||Internal Medicine||31/12/2015|
|Prof Massimo Pinzani||Liver and Digestive Health||Permanent|
UCL Medical School
|Dr Ann Griffin||Academic Centre for Medical Education, UCLMS||TBC|
Division of Surgery and Interventional Science
|Prof Vivek Mudera||Tissue and Materials||30/09/2016|
|Dr Marilena Loizidou||Nanotechnology||30/09/2016|
|Prof Laurence Lovat||Tissue and Energy||30/09/2016|
|Prof David Linch||Haematology||None|
Prof Daniel Hochhauser
|Prof Adrienne Flanagan||Pathology||None|
|Prof Jonathan Lederman||Clinical Trials Centre||None|
|Prof Henning Walczak||Cancer Biology||14/12/2019|
Eastman Dental Institute
|Prof Nikos Donos||Clinical Research||TBC|
|Prof Jonathan Knowles||Biomaterials and Tissue Engineering||TBC|
|Dr Sean Nair||Microbial Diseases||TBC|
Division of Infection and Immunity
|Prof Judy Breuer||Infection||31/03/2016|
|Prof Hans Stauss||Immunology||TBC|
Faculty of Population Health Sciences
Institute for Women's Health
|Prof Judith Stephenson||Reproductive Health||30-Sep-16|
|Prof Donald Peebles||Maternal and Fetal Medicine||30-Sep-16|
|Prof Nicola Robertson||Neonatology||30-Sep-16|
|Prof Martin Widschwendter||Women's Cancer||30-Sep-16|
|Dr Gwyneth Lewis||Global Women's Health||30-Sep-16|
|Prof Alexey Zaikin||Methodological Support||30-Sep-16|
Institute of Cardiovascular Sciences
|Prof Bill McKenna||Inherited Cardiac Disease||31-Jul-16|
|Prof John Deanfield||National Centre for Cardiovascular disease Prevention and Outcomes||31-Jul-16|
|Prof Andrew Taylor||Cardiovascular Imaging||31-Jul-16|
|Prof Steve Humphries||Cardiovascular Genetics||31-Jul-16|
|Prof Derek Yellon||Hatter Cardiovascular Institute||31-Jul-16|
|Prof Chris McGregor||Cardiovascular Surgery||31-Jul-16|
|Prof. Nish Chaturvedi||Cardiometabolic Phenotyping Group||30-Sep-18|
|Prof. Aroon Hingorani||Genetic Epidemiology Group||31-Jul-16|
Institute of Child Health
|Prof Andrew Copp||Developmental Biology and Cancer||31-Mar-17|
|Prof Phil Beales||Genetics and Genomic Medicine||31-Mar-17|
|Prof Catherine Law||Population, Policy and Practice||31-Mar-17|
|Prof Francesco Muntoni||Developmental Biology and Cancer||31-Mar-17|
|Prof Adrian Thrasher||Infection, Immunity, Inflammation and Physiological Medicine||31-Mar-17|
Institute of Clinical Trials & Methodology
|Prof Max Parmar||MRC Clinical Trials Unit at UCL||TBC|
|Prof Peter Brocklehurst||Comprehensive Clinical Trials Unit||TBC|
Institute of Health Informatics
|Prof Harry Hemingway||Farr Institute for Health Informatics Research||TBC|
|Dr Paul Taylor||Health Informatics & Multiprofessional Education (CHIME)||31-Jul-14|
Institute of Epidemiology & Health Care
|Prof Richard Watt||Epidemiology & Public Health||30-Sep-14|
|Dr Richard Gilson||Infection & Population Health||31-Dec-15|
|Prof Irwin Nazareth||Primary Care & Population Health||30-Sep-16|
|Prof Rosalind Raine||Applied Health Research||30-Sep-16|
|Prof Di Kuh||MRC Unit for Lifelong Health Ageing||30-Sep-16|
UCL’s Excellence Fellowship
Programme seeks to recruit the highest calibre early career researchers
from across the globe, supporting them to establish their
independent career and become the research leaders of the future.
UCL’s Springboard Population Science Fellowship Programme seeks to recruit the highest calibre early career researchers from across the globe, supporting them to establish their independent career and become the research leaders of the future in Population Science.
The School produces a range of publications including an ongoing series that showcases some of the outstanding research being carried out within the School and with collaborators across UCL, in London, nationally and internationally.